At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CJMB Callan JMB Inc.
Post-Mkt 05-15 18:42:04 EDT
1.01
+0.01
+1.04%
盘后1.01
+0.000.00%
16:00 EDT
High1.03Low0.9500Vol16.10K
Open1.03D1 Closing0.9996Amplitude8.00%
Mkt Cap5.68MTradable Cap1.41MTotal Shares5.63M
T/O15.84KT/O Rate1.15%Tradable Shares1.39M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Callan Jmb Q1 EPS $(0.59) Down From $(0.32) YoY, Sales $1.106M Down From $1.449M YoY
Benzinga  ·  28 minutes ago
Callan Jmb Q1 EPS $(0.59) Down From $(0.32) YoY, Sales $1.106M Down From $1.449M YoY
Callan JMB Q1 FY26 net loss widens 159% to $3.22 million; revenue falls 24% to $1.11 million
Reuters  ·  04:05
Callan JMB Q1 FY26 net loss widens 159% to $3.22 million; revenue falls 24% to $1.11 million
Callan JMB announces The Atlas Complex in Alabama
TIPRANKS  ·  04-20
Callan JMB announces The Atlas Complex in Alabama
Callan JMB signs partnership agreement with India’s Walker’s Pharmaceuticals for Atlas Complex
Reuters  ·  04-20
Callan JMB signs partnership agreement with India’s Walker’s Pharmaceuticals for Atlas Complex
Callan Jmb Inc - Intends to Pursue Foreign-Trade Zone Subzone Designation for Atlas Complex
THOMSON REUTERS  ·  04-20
Callan Jmb Inc - Intends to Pursue Foreign-Trade Zone Subzone Designation for Atlas Complex
Callan Jmb Inc - Atlas Complex Expected to Bring 250–300 Jobs and Long-Term Capital Investment to Marion
THOMSON REUTERS  ·  04-20
Callan Jmb Inc - Atlas Complex Expected to Bring 250–300 Jobs and Long-Term Capital Investment to Marion
Callan Jmb Inc - Announces Atlas Complex, 150 Acre Campus in Alabama for Pharmaceutical Onshoring
THOMSON REUTERS  ·  04-20
Callan Jmb Inc - Announces Atlas Complex, 150 Acre Campus in Alabama for Pharmaceutical Onshoring
Callan Jmb: Complaint Filed by Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, or Ongoing Projects
THOMSON REUTERS  ·  04-18
Callan Jmb: Complaint Filed by Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, or Ongoing Projects
Callan JMB faces lawsuit filed by Eddie Patent Holdings in Texas federal court
Reuters  ·  04-18
Callan JMB faces lawsuit filed by Eddie Patent Holdings in Texas federal court
Callan JMB gets Nasdaq notice for falling below $2.5 million equity requirement
Reuters  ·  04-11
Callan JMB gets Nasdaq notice for falling below $2.5 million equity requirement
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
GlobeNewswire  ·  04-07
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
Callan JMB FY25 operating loss widens to $7.0 million; revenue falls to $5.7 million
Reuters  ·  04-01
Callan JMB FY25 operating loss widens to $7.0 million; revenue falls to $5.7 million
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update
GlobeNewswire  ·  04-01
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update
Callan JMB to provide oversight for JKB-122 manufacturing scale-up
TIPRANKS  ·  03-27
Callan JMB to provide oversight for JKB-122 manufacturing scale-up
Callan JMB joins DifGen, Aveva, Attune Biotech, SGP in JKB-122 immune platform scale-up collaboration; provides independent manufacturing and supply chain oversight
Reuters  ·  03-27
Callan JMB joins DifGen, Aveva, Attune Biotech, SGP in JKB-122 immune platform scale-up collaboration; provides independent manufacturing and supply chain oversight
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
GlobeNewswire  ·  03-27
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
Top Executive Makes Bold Insider Move at Callan JMB, Inc.
TIPRANKS  ·  03-27
Top Executive Makes Bold Insider Move at Callan JMB, Inc.
Callan JMB; Chief Medical Officer David J. Croyle acquires 10,195 common shares valued at $17,841
Reuters  ·  03-27
Callan JMB; Chief Medical Officer David J. Croyle acquires 10,195 common shares valued at $17,841
Callan JMB, Attune Biotech partner for clinical trials for lodonal
TIPRANKS  ·  03-11
Callan JMB, Attune Biotech partner for clinical trials for lodonal
Callan JMB Inc. partners with Attune Biotech to oversee lodonal IND manufacturing and quality control
Reuters  ·  03-11
Callan JMB Inc. partners with Attune Biotech to oversee lodonal IND manufacturing and quality control

Introduction

Company Name.
Callan JMB Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--